{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:18:29Z","timestamp":1759537109290,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Juvenile myelomonocytic leukemia (JMML) is a rare pediatric myelodysplastic\/myeloproliferative neoplasm characterized by distinct epigenetic signatures that facilitate molecular classification. This study aimed to evaluate the diagnostic utility of locus-specific DNA methylation in the bone morphogenetic protein 4 (<jats:italic>BMP4<\/jats:italic>) gene as a single predictor of disease outcomes in a cohort of 111 children diagnosed with JMML, alongside 9 healthy controls. Methylation levels of <jats:italic>BMP4<\/jats:italic>, assessed through targeted bisulfite next-generation sequencing (bs-NGS), were heterogeneous within the JMML cohort and were significantly associated with clinical risk factors, such as patient age, and fetal hemoglobin (HbF) levels. A comparative analysis of <jats:italic>BMP4<\/jats:italic> bs-NGS and genome-wide methylation array data revealed a strong positive correlation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The sensitivity and specificity of <jats:italic>BMP4<\/jats:italic> bs-NGS for classifying high-methylation cases were 0.612 and 0.887, respectively. For <jats:italic>PTPN11<\/jats:italic>-mutant patients (<jats:italic>N\u2009<\/jats:italic>=\u200940), the sensitivity was 0.667 and the specificity was 0.842. Survival analysis indicated that patients with high <jats:italic>BMP4<\/jats:italic> methylation (<jats:italic>BMP4<\/jats:italic>h) had lower 5-year disease-free survival (DFS) rates than those with normal <jats:italic>BMP4<\/jats:italic> methylation (<jats:italic>BMP4<\/jats:italic>n). Specifically, the 20% of patients with highest <jats:italic>BMP4<\/jats:italic> methylation had a 5-year DFS of 0.38, in contrast to 0.62 for the lowest 20% (<jats:italic>p<\/jats:italic>\u2009=\u20090.007). These findings highlight the potential of <jats:italic>BMP4<\/jats:italic> methylation analysis as a complementary biomarker for JMML risk stratification, mirroring genome-wide methylation profiles known to associate with prognostic subgroups.<\/jats:p>","DOI":"10.1186\/s13148-025-01983-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:40:39Z","timestamp":1759462839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus"],"prefix":"10.1186","volume":"17","author":[{"given":"Foued","family":"Ghanjati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Heck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Lebrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"N\u00f6llke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rotari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlou","family":"Schoof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Sch\u00f6nung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Sukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hasle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Buechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ussowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Catala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Turkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Schmugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Flotho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"10","key":"1983_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","volume":"133","author":"CM Niemeyer","year":"2019","unstructured":"Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who\u2019s the driver at the wheel? Blood. 2019;133(10):1060\u201370.","journal-title":"Blood"},{"key":"1983_CR2","unstructured":"Niemeyer, C.M., et al. 1997 Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 89(10) 3534\u201343."},{"issue":"1","key":"1983_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","volume":"105","author":"F Locatelli","year":"2005","unstructured":"Locatelli F, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG MDS\/EBMT trial. Blood. 2005;105(1):410\u20139.","journal-title":"Blood"},{"issue":"1","key":"1983_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.leu.2401240","volume":"13","author":"C Flotho","year":"1999","unstructured":"Flotho C, et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia. 1999;13(1):32\u20137.","journal-title":"Leukemia"},{"issue":"8","key":"1983_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ng.2698","volume":"45","author":"H Sakaguchi","year":"2013","unstructured":"Sakaguchi H, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45(8):937\u201341.","journal-title":"Nat Genet"},{"issue":"11","key":"1983_CR6","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.3324\/haematol.2018.189977","volume":"103","author":"M Hofmans","year":"2018","unstructured":"Hofmans M, et al. The long non-coding RNA landscape in juvenile myelomonocytic leukemia. Haematologica. 2018;103(11):e501\u20134.","journal-title":"Haematologica"},{"issue":"11","key":"1983_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/ng.3420","volume":"47","author":"A Caye","year":"2015","unstructured":"Caye A, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015;47(11):1334\u201340.","journal-title":"Nat Genet"},{"issue":"14","key":"1983_CR8","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","volume":"131","author":"N Murakami","year":"2018","unstructured":"Murakami N, et al. Integrated molecular profiling of juvenile myelomonocytic leukemia. Blood. 2018;131(14):1576\u201386.","journal-title":"Blood"},{"issue":"1","key":"1983_CR9","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-017-02178-9","volume":"8","author":"E Stieglitz","year":"2017","unstructured":"Stieglitz E, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun. 2017;8(1):2127.","journal-title":"Nat Commun"},{"issue":"1","key":"1983_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41467-017-02177-w","volume":"8","author":"DB Lipka","year":"2017","unstructured":"Lipka DB, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017;8(1):2126.","journal-title":"Nat Commun"},{"issue":"1","key":"1983_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/1078-0432.CCR-20-3184","volume":"27","author":"M Schonung","year":"2021","unstructured":"Schonung M, et al. International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res. 2021;27(1):158\u201368.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"1983_CR12","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1182\/blood-2010-08-298968","volume":"117","author":"C Olk-Batz","year":"2011","unstructured":"Olk-Batz C, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood. 2011;117(18):4871\u201380.","journal-title":"Blood"},{"issue":"6","key":"1983_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/er.2002-0003","volume":"23","author":"H Chang","year":"2002","unstructured":"Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002;23(6):787\u2013823.","journal-title":"Endocr Rev"},{"issue":"1","key":"1983_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1359-6101(97)00036-1","volume":"9","author":"M Kawabata","year":"1998","unstructured":"Kawabata M, Imamura T, Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 1998;9(1):49\u201361.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"1983_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1634\/stemcells.22-4-457","volume":"22","author":"TJ Sadlon","year":"2004","unstructured":"Sadlon TJ, Lewis ID, D\u2019Andrea RJ. BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells. 2004;22(4):457\u201374.","journal-title":"Stem Cells"},{"issue":"20","key":"1983_CR16","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1182\/blood-2009-02-206433","volume":"114","author":"DC Goldman","year":"2009","unstructured":"Goldman DC, et al. BMP4 regulates the hematopoietic stem cell niche. Blood. 2009;114(20):4393\u2013401.","journal-title":"Blood"},{"issue":"1","key":"1983_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s12276-019-0357-5","volume":"52","author":"S Jeong","year":"2020","unstructured":"Jeong S, et al. BMP4 and perivascular cells promote hematopoietic differentiation of human pluripotent stem cells in a differentiation stage-specific manner. Exp Mol Med. 2020;52(1):56\u201365.","journal-title":"Exp Mol Med"},{"key":"1983_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143084","author":"C Mayerhofer","year":"2021","unstructured":"Mayerhofer C, Niemeyer CM, Flotho C. Current treatment of juvenile myelomonocytic leukemia. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10143084.","journal-title":"J Clin Med"},{"issue":"11","key":"1983_CR19","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"issue":"21","key":"1983_CR20","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/sj.onc.1207483","volume":"23","author":"JM Ordway","year":"2004","unstructured":"Ordway JM, Williams K, Curran T. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos Ras or Dnmt1. Oncogene. 2004;23(21):3737\u201348.","journal-title":"Oncogene"},{"issue":"12","key":"1983_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145394","volume":"10","author":"H Sakaguchi","year":"2015","unstructured":"Sakaguchi H, et al. Aberrant DNA methylation is associated with a poor outcome in juvenile myelomonocytic leukemia. PLoS ONE. 2015;10(12):e0145394.","journal-title":"PLoS ONE"},{"issue":"24","key":"1983_CR22","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1182\/bloodadvances.2021005080","volume":"5","author":"H Kitazawa","year":"2021","unstructured":"Kitazawa H, et al. Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. Blood Adv. 2021;5(24):5507\u201318.","journal-title":"Blood Adv"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01983-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01983-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01983-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:40:42Z","timestamp":1759462842000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01983-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01983-0","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Genomic studies and the use of primary bone marrow and blood specimens were approved by the institutional review board (Ethics committee of the University of Freiburg), votes: 247\/05, 526\/18.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}